| 摘要 |
PROBLEM TO BE SOLVED: To provide use of FGF-18 particularly in treatment of cartilage disorder and osteoarthritis, more specifically, in a regimen for treatment of a patient having cartilage disorder such as osteoarthritis, for example, knee osteoarthritis or secondary hip osteoarthritis and in production of an agent for treatment thereof.SOLUTION: Specifically, a preferable treatment scheme comprises administration of a FGF-18 compound once a week per 1 treatment cycle. |
